CSIMarket
 


Chelsea Therapeutics International, Ltd.  (CHTP)
Other Ticker:  
 

Chelsea Therapeutics International Ltd.'s Tangible Leverage Ratio

CHTP's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


Due to net new borrowings of 22.39%, Tangible Leverage Ratio fell to 0.12, below the Chelsea Therapeutics International Ltd.'s average Tangible Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the first quarter 2014, 12 other companies have achieved lower Tangible Leverage Ratio than Chelsea Therapeutics International Ltd. in the I Quarter 2014. While Tangible Leverage Ratio total ranking has deteriorated compared to the forth quarter 2013 from 158 to 295 .

Explain Tangible Leverage Ratio?
What is CHTP Market Share?
What are CHTP´s Total Liabilities?


CHTP Tangible Leverage Ratio (Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter
(Sep 30 2013)
III. Quarter
(Jun 30 2013)
II. Quarter
(Dec 31 2012)
IV. Quarter
Y / Y Tangible Equity Change 32.69 % 56.19 % -43 % - -
Y / Y Total Liabilities Change 31.96 % -46.89 % -66.14 % - -
Tangible Leverage Ratio MRQ 0.12 0.08 0.15 0.14 0.12
CHTP's Total Ranking # 295 # 158 # 261 # 277 #
Seq. Tangible Equity Change -20.5 % 125.39 % -2.95 % -23.7 % -6.42 %
Seq. Total Liabilities Change 22.39 % 9.92 % 5.48 % -7.01 % -50.74 %



Tangible Leverage Ratio first quarter 2014 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 87
Overall Market # 238


Tangible Leverage Ratio Statistics
High Average Low
0.26 0.15 0.08
(Jun 30 2012)   (Dec 31 2013)




Financial Statements
Chelsea Therapeutics International Ltd.'s Tangible Equity $ 34 Millions Visit CHTP's Balance sheet
Chelsea Therapeutics International Ltd.'s Total Liabilities $ 4 Millions Visit CHTP's Balance sheet
Source of CHTP's Sales Visit CHTP's Sales by Geography


Cumulative Chelsea Therapeutics International Ltd.'s Tangible Leverage Ratio

CHTP's Tangible Leverage Ratio for the trailling 12 Months

CHTP Tangible Leverage Ratio

(Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter
(Sep 30 2013)
III. Quarter
(Jun 30 2013)
II. Quarter
(Dec 31 2012)
IV. Quarter
Y / Y Tangible Equity TTM Growth 32.69 % 56.19 % -43 % - -
Y / Y Total Liabilities TTM Growth 31.96 % -46.89 % -66.14 % - -
Tangible Leverage Ratio TTM 0.11 0.11 0.16 0.19 0.2
Total Ranking TTM # 104 # 5 # 5 # 5 #
Seq. Tangible Equity TTM Growth -20.5 % 125.39 % -2.95 % -23.7 % -6.42 %
Seq. Total Liabilities TTM Growth 22.39 % 9.92 % 5.48 % -7.01 % -50.74 %


On the trailing twelve months basis Despite of the net new borrowings of 22.39% during the twelve months period ending in I Quarter 2014 Chelsea Therapeutics International Ltd. has managed to unchanged Tangible Leverage Ratio in the I Quarter 2014 to 0.11, below Chelsea Therapeutics International Ltd.'s average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 12, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than Chelsea Therapeutics International Ltd.. While Tangible Leverage Ratio total ranking has deteriorated during the twelve months ending in the I Quarter 2014, compared to the prior period, from 5 to 104.

Explain Tangible Leverage Ratio?
What is CHTP Market Share?
What are CHTP´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 87
Within the Market # 104


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
0.26 0.15 0.08
(Jun 30 2012)   (Dec 31 2013)




Companies with similar Tangible Leverage Ratio in the quarter ending Mar 31 2014, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioMar 31 2014 MRQ Total LiabilitiesMar 31 2014 MRQ Tangible Equity
Aevi Genomic Medicine, Inc.  0.30 $ 4.657  Millions$ 15.594  Millions
Vaxart Inc   0.25 $ 23.600  Millions$ 95.800  Millions
Novavax inc  0.24 $ 27.539  Millions$ 116.521  Millions
Acceleron Pharma inc  0.24 $ 42.583  Millions$ 180.457  Millions
Anavex Life Sciences Corp   0.22 $ 1.884  Millions$ 8.408  Millions
Genocea Biosciences Inc   0.20 $ 11.332  Millions$ 55.373  Millions
Premier Biomedical Inc  0.20 $ 0.021  Millions$ 0.102  Millions
Eloxx Pharmaceuticals Inc   0.18 $ 1.155  Millions$ 6.251  Millions
Momenta Pharmaceuticals inc   0.18 $ 42.945  Millions$ 242.366  Millions
Sangamo Therapeutics Inc   0.18 $ 37.800  Millions$ 213.970  Millions
La Jolla Pharmaceutical Company  0.17 $ 0.906  Millions$ 5.223  Millions
Pluri Inc   0.17 $ 11.430  Millions$ 65.958  Millions
Ladrx Corporation  0.17 $ 16.798  Millions$ 97.857  Millions
Cellular Biomedicine Group Inc   0.14 $ 1.819  Millions$ 12.652  Millions
Receptos, Inc.  0.14 $ 20.123  Millions$ 141.023  Millions
Neurocrine Biosciences Inc   0.13 $ 32.239  Millions$ 247.057  Millions
Chelsea Therapeutics International, Ltd.  0.12 $ 3.974  Millions$ 34.389  Millions
Enzon Pharmaceuticals inc   0.10 $ 1.444  Millions$ 13.773  Millions
Repligen Corp  0.10 $ 10.483  Millions$ 101.942  Millions
Bio techne Corp  0.10 $ 53.525  Millions$ 536.277  Millions
Fate Therapeutics Inc   0.10 $ 4.390  Millions$ 45.177  Millions
Aceragen Inc   0.08 $ 5.358  Millions$ 66.882  Millions
Fresh Tracks Therapeutics Inc   0.08 $ 4.518  Millions$ 56.725  Millions
Iovance Biotherapeutics Inc   0.08 $ 1.277  Millions$ 16.806  Millions
Pharmacyte Biotech Inc   0.07 $ 0.374  Millions$ 5.393  Millions
Aerie Pharmaceuticals Inc   0.06 $ 3.690  Millions$ 62.271  Millions
Organovo Holdings Inc   0.04 $ 1.902  Millions$ 48.284  Millions
Eiger Biopharmaceuticals Inc   0.03 $ 1.789  Millions$ 54.581  Millions
Nutrastar International Inc.  0.03 $ 3.190  Millions$ 117.626  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com